Streetwise Reports' Article Archives — Current Month (7)

Is This Pharma Set To Break Out After COPD Drug Approval? (03/15/2024)

Clinical-stage biopharmaceutical company Verona Pharma Plc is looking toward a pivotal year as its new chronic obstructive pulmonary disease (COPD) drug ensifentrine nears possible approval by the FDA. At least two research companies have named it a top pick for 2024.

more>

This Biotech Is a Potential Disruptor, Expert Says (03/12/2024)

Chris Temple of The National Investor shares why he believes BetterLife Pharma Inc. is an Immediate Buy.

more>

Wellness Co.'s New Initiatives Should 'Lower Barriers' Analysts Say (03/12/2024)

The Beachbody Company Inc.'s 4Q23 results have Roth MKM analysts maintaining their Buy rating.

more>

Safe Supply Firm Announces Another Promising Acquisition (03/11/2024)

Safe Supply Streaming Co. adds another company to its portfolio, and continues advocating for harm reduction in the psychedelic sector.

more>

Healthcare AI Firm Has 'Bright Future,' Analyst Predicts (03/08/2024)

Canadian artificial intelligence (AI) and machine learning healthcare firm Treatment.com AI is breaking into the global healthcare AI market predicted to be worth US$187 billion by the end of the decade.

more>

NY Biotech Has Potentially Game Changing Anxiety Therapy (03/07/2024)

Mind Medicine (MindMed) Inc. recently announced positive results from its Phase 2b trial of MM120 in generalized anxiety disorder, according to a Roth MKM research note.

more>

Bionic Medical Co. Has Sufficient Funds to Operate Through 2024 (03/05/2024)

Ekso Bionics Holdings Inc.'s fourth quarter of 2023 financial results were in line with estimates, according to H.C. Wainwright & Co.

more>

More Archives

2024Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes